Priority area 40 | Livro Branco das Farmácias Portuguesas

Dimension III

PRIORITY AREA 40. GENERATING REAL-WORLD EVIDENCE

Every day, during their activity, the pharmacy network generates and collects a large volume of data that reflects their interactions with the population, their behaviours and health outcomes. Said data can be used to characterise the therapeutic journey, demonstrate safety and efficacy in complex contexts, help define health policies or support the approval of the introduction of new medicines onto the market or a review of their marketing models through real-world observational data.¹ In this sense, promoting pharmacies as places that generate real-world data and evidence is crucial.

1. Garrison LP, Neumann PJ, Erickson P, et al. Using Real-World Data for Coverage and Payment Decisions: The ISPOR Real-World Data Task Force Report. Value in Health 2007;10:326–35. doi:10.1111/j.1524-4733.2007.00186.x.

PROPOSALS FOR ACTION

Promoting the role of community pharmacies as central stakeholders in the generation of health evidence, ensuring that the generation of evidence is one of the pharmacies’ competencies.

Setting up pharmacy user registers, whether they are disease or treatment registers, in line with international data quality and interoperability standards so as to enable future integration into cross-border RWE generation initiatives (e.g. DARWIN EU®).

Integrating standardised primary data collection instruments (validated scales, structured questionnaires, etc.) into the pharmacies’ IT system.

Promotion of remuneration models for pharmacies for their role in generating real-world evidence.